シングルセルオミックスの世界市場：2023-2030年

世界のシングルセルオミックス市場は、予測期間（2023-2030年）にCAGR 18.2％で成長すると予測されています。多くのがんセンターや世界製薬企業によるトランスレーショナルリサーチや臨床開発のためのタペストリ・プラットフォーム採用の増加は、シングルセル・マルチオミクスの必要性を実証しています。シングルセルオミックスは、ほとんどの電子機器から簡単にアクセスできるため、機動性のあるソリューションを提供します。シングルセル・オミクスは、幅広い生物医学研究分野に応用され、急速に成長している分野です。この技術がより身近で手頃なものになるにつれて、世界中の研究者に採用されるようになっています。

セグメント別の展望

シングルセルオミックスの世界市場において、オンコロジーサブセグメントが大きなシェアを占めると予想されます。

用途の中でも、オンコロジーサブセグメントは世界のシングルセルオミックス市場でかなりのシェアを占めると予想されています。このセグメントの成長は、がんの有病率の増加や、がんの進行の研究におけるシングルセル解析のアプリケーションの増加が、がんの細胞生物学を理解するためのオミックス技術の需要を促進すると予測されているなどのいくつかの要因に起因しています。例えば、2023年6月、オーキン社、ナノストリング社、世界有数のがん研究機関であるピッツバーグ大学、ギュスターヴ・ルーシー、ローザンヌ大学病院、Uniklinikum Erlangen/Friedrich-Alexander-Universitat Erlangen-Nurnberg、Charite-Universitatsmedizin Berlinは、米国臨床腫瘍学会の年次総会でMOSAIC（Multi Omic Spatial Atlas In Cancer）を発表します。MOSAICは、腫瘍の構造に関する前例のない情報を提供する一連の最先端技術である空間オミクスの利用を通じて、がん研究に革命を起こす画期的な5,000万米ドルのプロジェクトです。

地域別展望

世界のシングルセルオミックス市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、南米）を含む地域別にさらに細分化されます。このうちアジア太平洋地域は、シングルセルオミックスによるスマートラーニングの採用が拡大していることから、世界全体で顕著なシェアを占めると予想されています。

北米地域は世界のシングルセルオミックス市場で大きなCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。同地域の成長は、医療インフラの改善と、同地域におけるより良い研究と製品開発のための市場参入企業による戦略的イニシアチブの増加に起因しています。例えば、2023年4月、ハイスループット単一細胞DNAおよびマルチオミクス解析のパイオニアであるMission Bio, Inc.は、臨床診断事業と治療開発事業を確立している技術系企業であるFulgent Geneticsと契約を締結したと発表しました。Fulgent Genetics社は、全ゲノム、全エクソーム、RNAシーケンス、腫瘍プロファイリング、メチル化シーケンス、リキッドバイオプシー、シングルセルシーケンス、空間生物学、病理学サービスなど、完全にカスタマイズ可能なサービスメニューでTapestriプラットフォームによるシングルセル・マルチオミクスを提供できるようになり、増大する製薬企業の顧客需要をサポートします。さらに、フルジェント・ジェネティクス社は、医薬品開発と承認プロセスを合理化するために、臨床開発におけるタペストリ・プラットフォームの応用を評価します。

また、同地域における投資活動の増加や政府の取り組みも市場を牽引しています。例えば、2023年11月、テキサスA&M大学システムは、ゲノム、栄養、健康の間の複雑なつながりを研究する学際的共同研究のために、国立衛生研究所（NIH）から119万米ドルの助成金を受け取っています。これらのつながりを理解することは、がんやその他の病気の診断や治療に役立つと思われます。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• 10x Genomics, Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Bio Rad Laboratories, Inc.
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Mission Bio, Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• シングルセルオミックスの世界市場：製品タイプ別
  • シングルセルゲノミクス
  • シングルセルトランスクリプトミクス
  • シングルセルプロテオミクス
  • シングルセルメタボロミクス
• シングルセルオミックスの世界市場：用途別
  • オンコロジー
  • 細胞生物学
  • 神経学
  • 免疫学
  • その他（微生物学）
• シングルセルオミックスの世界市場：エンドユーザー別
  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • 病院・診断研究所

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• Becton, Dickinson and Company
• Berkeley Lights Inc
• BGI Genomics Co. Ltd
• Danaher Corp（Cytiva Life Sciences）
• Dolomite Bio
• Epicypher Inc.
• Fluidigm Corp
• Illimina, Inc
• Miltenyi Biotec B.V. & CO.
• Nanostring Technologies, Inc
• Olink Holding AB（Olink Proteomics）
• Parse Bioscience
• Qiagen N.V.
• Takara Holdings Inc. Takara Bio Group
• Thermo Fisher Scientific, Inc.

LIST OF TABLES

• 1. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
• 2. GLOBAL GENOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 3. GLOBAL TRANSCRIPTOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL PROTEOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 5. GLOBAL METABOLOMICS SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 6. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 7. GLOBAL ONCOLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 8. GLOBAL CELL BIOLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 9. GLOBAL NEUROLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 10. GLOBAL IMMUNOLOGY IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 11. GLOBAL OTHER APPLICATIONS IN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 12. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 13. GLOBAL SINGLE-CELL OMICS FOR PHARMA AND BIOTECH COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 14. GLOBAL SINGLE-CELL OMICS FOR ACADEMIC AND RESEARCH ORGANIZATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 15. GLOBAL SINGLE-CELL OMICS FOR HOSPITAL AND DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 16. GLOBAL SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 17. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 18. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
• 19. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 20. NORTH AMERICAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 21. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 22. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
• 23. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 24. EUROPEAN SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 25. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 26. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
• 27. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 28. ASIA- PACIFIC SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 29. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 30. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
• 31. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 32. REST OF THE WORLD SINGLE-CELL OMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY PRODUCT TYPE, 2022 VS 2030 (%)
• 2. GLOBAL GENOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL TRANSCRIPTOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL PROTEOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL METABOLOMICS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 6. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
• 7. GLOBAL ONCOLOGY SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL CELL BIOLOGY REALITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL NEUROLOGY SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 10. GLOBAL IMMUNOLOGY SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 11. GLOBAL OTHER APPLICATIONS SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 12. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY END-USER, 2022 VS 2030 (%)
• 13. GLOBAL SINGLE-CELL OMICS FOR PHARMA AND BIOTECH COMPANIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 14. GLOBAL SINGLE-CELL OMICS FOR ACADEMIC AND RESEARCH ORGANIZATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 15. GLOBAL SINGLE-CELL OMICS FOR HOSPITAL AND DIAGNOSTIC LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 16. GLOBAL SINGLE-CELL OMICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 17. US SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 18. CANADA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 19. UK SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 20. FRANCE SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 21. GERMANY SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 22. ITALY SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 23. SPAIN SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 24. REST OF EUROPE SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 25. INDIA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 26. CHINA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 27. JAPAN SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 28. SOUTH KOREA SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 29. REST OF ASIA-PACIFIC SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)
• 30. REST OF THE WORLD SINGLE-CELL OMICS MARKET SIZE, 2022-2030 ($ MILLION)

Title: Global Single-cell omics Market Size, Share & Trends Analysis Report by product Type (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, and Single-Cell Metabolomics), by Application (Oncology, Cell Biology, Neurology, Immunology, and Other) and by End User (Pharmaceutical & Biotechnology Companies, Academic and Research Organizations and Hospital and Diagnostic Laboratories),Forecast Period (2023-2030).

The global Single-cell omics market is anticipated to grow at a CAGR of 18.2% during the Forecast Period (2023-2030). The increasing adoption of the Tapestri Platform for translational research and clinical development by many cancer centers and global pharma companies demonstrates the necessity of single-cell multi-omics. Single-cell omics provides mobility solutions as they are easily accessible via most electronic devices. Single-cell omics is a rapidly growing field with applications in a wide range of biomedical research areas. As the technology becomes more accessible and affordable, it is being adopted by researchers globally.

Segmental Outlook

The global Single-cell omics market is segmented on the product type, application, and end user. Based on the product type, the market is sub-segmented into single-cell genomics, single-cell transcriptomics, single-cell proteomics, and single-cell metabolomics. Based on application, the market is sub-segmented into oncology, cell biology, neurology, immunology and other. And based on the end user, the market is sub-segmented into pharmaceutical & biotechnology companies, academic and research organizations and hospital and diagnostic laboratories. among the end user, the academic and research organizations sub-segment is anticipated to hold a considerable share of the market, owing to the spike in the number of research projects that are currently underway at private and government academic and research organizations.

The Oncology Sub-Segment is Anticipated to Hold a Considerable Share of the Global Single-cell omics Market

Among the application, the Oncology sub-segment is expected to hold a considerable share of the global Single-cell omics market. This segmental growth is attributed to several factor such as, increasing prevalence of cancer and rising applications of single-cell analysis in studying cancer progression is projected to fuel the demand for omics technology in understanding the cell biology of cancer. For instance, In June 2023, Owkin, Nanostring and world-leading cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universitat Erlangen-Nurnberg, and Charite - Universitatsmedizin Berlin are launching MOSAIC (Multi Omic Spatial Atlas In Cancer) at the American Society of Clinical Oncology's annual meeting. MOSAIC is a landmark $50 million project to revolutionize cancer research through the use of spatial omics, a set of cutting-edge technologies that offer unprecedented information on the structure of tumors.

Regional Outlook

The global Single-cell omics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to growing adoption of smart learning through Single-cell omics.

The North America Region is Expected to Grow at a Significant CAGR in the Global Single-cell omics Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to improving medical infrastructure and increasing strategic initiatives by market player for better research and product development in the regions. For instance, in April 2023, Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced that it has entered into an agreement with Fulgent Genetics, a technology-based company with a well-established clinical diagnostic business and a therapeutic development business. Fulgent Genetics is now able to offer single-cell multi-omics on the Tapestri Platform on its fully customizable menu of services, including whole genome, whole exome, RNA sequencing, tumor profiling, methylation sequencing, liquid biopsy, single-cell sequencing, spatial biology, and pathology services to support its growing pharma client demands. Additionally, Fulgent Genetics will evaluate the Tapestri Platform for applications in clinical development to streamline the drug development and approval process.

Also, increasing investing activities and government initiatives in the region, are also driving the market. For instance, in November 2023, The Texas A&M University System has received a $1.19 million grant from the National Institutes of Health (NIH) for a multidisciplinary collaboration to study the intricate connections between genomics, nutrition and health. Understanding these connections will help in the diagnosis and treatment of cancer and other diseases.

Market Players Outlook

The major companies serving the Single-cell omics market include: Becton, Dickinson and Company, Berkeley Lights Inc, BGI Genomics Co. Ltd, Danaher Corp, Dolomite Bio, Epicypher Inc., Fluidigm Corp, Illimina, Inc, Miltenyi Biotec B.V. & CO., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In August 2023, Scale Biosciences, Inc. announced an expansion of their product portfolio to enable a broader range of single cell omics experiments and unlock new translational research applications. New products include the ScaleBio Single Cell Methylation Kit, ScaleBio Single Cell CRISPR Guide Enrichment Kit, Scale-plex Kit, and additional capabilities for the company's existing ScaleBio Single Cell RNA Sequencing Kit to facilitate more diverse experimental designs and broader use of translational samples leveraging innovative, scalable, and accessible tools to democratize single cell omics across research applications without the need for additional instrumentation.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global Single-cell omics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. 10x Genomics, Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Bio Rad Laboratories, Inc.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Mission Bio, Inc.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Single-cell Omics Market by Product Type
  • 4.1.1. Single-Cell Genomics
  • 4.1.2. Single-Cell Transcriptomics
  • 4.1.3. Single-Cell Proteomics
  • 4.1.4. Single-Cell Metabolomics
• 4.2. Global Single-cell Omics Market by Application
  • 4.2.1. Oncology
  • 4.2.2. Cell Biology
  • 4.2.3. Neurology
  • 4.2.4. Immunology
  • 4.2.5. other (Microbiology)
• 4.3. Global Single-cell Omics Market by End-User
  • 4.3.1. Pharma and biotech companies
  • 4.3.2. Academic and Research Organizations
  • 4.3.3. Hospital and Diagnostic Laboratories

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Becton, Dickinson and Company
• 6.2. Berkeley Lights Inc
• 6.3. BGI Genomics Co. Ltd
• 6.4. Danaher Corp (Cytiva Life Sciences)
• 6.5. Dolomite Bio
• 6.6. Epicypher Inc.
• 6.7. Fluidigm Corp
• 6.8. Illimina, Inc
• 6.9. Miltenyi Biotec B.V. & CO.
• 6.10. Nanostring Technologies, Inc
• 6.11. Olink Holding AB (Olink Proteomics)
• 6.12. Parse Bioscience
• 6.13. Qiagen N.V.
• 6.14. Takara Holdings Inc. Takara Bio Group
• 6.15. Thermo Fisher Scientific, Inc.